EB01 Cream Placebo
EB01-01-2018
Phase 2 small_molecule completed
Quick answer
EB01 Cream Placebo for Allergic Contact Dermatitis is a Phase 2 program (small_molecule) at Edesa Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Edesa Biotech
- Indication
- Allergic Contact Dermatitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed